Acrivon Therapeutics (ACRV) insider trading in the last 6 months
6 insiders sold $46K. No buys.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Form 4 filings, newest first
Who files at Acrivon Therapeutics
Questions about ACRV's insider trades
Are ACRV insiders buying or selling?
6 insiders sold $46K across 17 filings in the last 6 months. No open-market buys on record. The newest filing: Peter Blume-Jensen, President and CEO, sold $2K on Nov 17, 2026.
Who are ACRV's biggest insider sellers?
By the dollars of their sales in the last 6 months: Peter Blume-Jensen (President and CEO), 5 sales; Mary Miller (Chief Legal Officer), 5 sales; Eric Devroe (Chief Operating Officer), 2 sales. 6 insiders sold in all.
When did an ACRV insider last buy?
No ACRV insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Peter Blume-Jensen on Nov 17, 2026.
Acrivon Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.